311 related articles for article (PubMed ID: 26498267)
1. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease.
Heeba GH; Morsy MA
Environ Toxicol Pharmacol; 2015 Nov; 40(3):907-14. PubMed ID: 26498267
[TBL] [Abstract][Full Text] [Related]
2. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
5. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
6. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
11. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation.
Cahova M; Palenickova E; Dankova H; Sticova E; Burian M; Drahota Z; Cervinkova Z; Kucera O; Gladkova C; Stopka P; Krizova J; Papackova Z; Oliyarnyk O; Kazdova L
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G100-11. PubMed ID: 26045616
[TBL] [Abstract][Full Text] [Related]
12. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of fucoidan against acetaminophen-induced liver injury.
Hong SW; Lee HS; Jung KH; Lee H; Hong SS
Arch Pharm Res; 2012 Jun; 35(6):1099-105. PubMed ID: 22870820
[TBL] [Abstract][Full Text] [Related]
15. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
16. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
Zheng Y; Liu T; Wang Z; Xu Y; Zhang Q; Luo D
Int J Biol Macromol; 2018 Jun; 112():929-936. PubMed ID: 29447962
[TBL] [Abstract][Full Text] [Related]
18. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
19. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
Saad ZA; Khodeer DM; Zaitone SA; Ahmed AAM; Moustafa YM
Life Sci; 2020 Jul; 253():117725. PubMed ID: 32348835
[TBL] [Abstract][Full Text] [Related]
20. Fucoidan alleviates high-fat diet-induced dyslipidemia and atherosclerosis in ApoE(shl) mice deficient in apolipoprotein E expression.
Yokota T; Nomura K; Nagashima M; Kamimura N
J Nutr Biochem; 2016 Jun; 32():46-54. PubMed ID: 27142736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
